These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22391630)

  • 1. Differential effects of cholesterol and budesonide on biophysical properties of clinical surfactant.
    Zhang H; Wang YE; Neal CR; Zuo YY
    Pediatr Res; 2012 Apr; 71(4 Pt 1):316-23. PubMed ID: 22391630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysical and chemical stability of surfactant/budesonide and the pulmonary distribution following intra-tracheal administration.
    Chen CM; Chang CH; Chao CH; Wang MH; Yeh TF
    Drug Deliv; 2019 Dec; 26(1):604-611. PubMed ID: 31204848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biophysical models in investigations of exogenous surfactant activities on the surface tension and their theurapeutic effectiveness].
    Todorov R; Iordanova A; Georgiev GA; Petkova Kh; Stoimenova E; Georgieva R; Khristova E; Vasiliev Kh; Lalchev Z
    Akush Ginekol (Sofiia); 2007; 46 Suppl 1():29-36. PubMed ID: 18175392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing an exogenous pulmonary surfactant-glucocorticoids association: Effect of corticoid concentration on the biophysical properties of the surfactant.
    Cimato A; Facorro G; Martínez Sarrasague M
    Respir Physiol Neurobiol; 2018 Jan; 247():80-86. PubMed ID: 28963086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biophysical Activity of Impaired Lung Surfactant upon Exposure to Polymer Nanoparticles.
    Beck-Broichsitter M
    Langmuir; 2016 Oct; 32(40):10422-10429. PubMed ID: 27641633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative assessment of inhaled drug particle-pulmonary surfactant interaction by atomic force microscopy.
    Davies MJ; Brindley A; Chen X; Doughty SW; Marlow M; Roberts CJ
    Colloids Surf B Biointerfaces; 2009 Oct; 73(1):97-102. PubMed ID: 19500951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structures of pulmonary surfactant films adsorbed to an air-liquid interface in vitro.
    Bachofen H; Gerber U; Gehr P; Amrein M; Schürch S
    Biochim Biophys Acta; 2005 Dec; 1720(1-2):59-72. PubMed ID: 16405864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keeping lung surfactant where it belongs: protein regulation of two-dimensional viscosity.
    Alonso C; Waring A; Zasadzinski JA
    Biophys J; 2005 Jul; 89(1):266-73. PubMed ID: 15833995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multilayer structures in lipid monolayer films containing surfactant protein C: effects of cholesterol and POPE.
    Malcharek S; Hinz A; Hilterhaus L; Galla HJ
    Biophys J; 2005 Apr; 88(4):2638-49. PubMed ID: 15653721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of pulmonary surfactant due to serum-inhibited adsorption and reversal by hydrophilic polymers: experimental.
    Taeusch HW; Bernardino de la Serna J; Perez-Gil J; Alonso C; Zasadzinski JA
    Biophys J; 2005 Sep; 89(3):1769-79. PubMed ID: 15923228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budesonide added to modified porcine surfactant Curosurf may additionally improve the lung functions in meconium aspiration syndrome.
    Mikolka P; Mokrá D; Kopincová J; Tomčíková-Mikušiaková L; Calkovská A
    Physiol Res; 2013; 62(Suppl 1):S191-200. PubMed ID: 24329699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical activity of animal-derived exogenous surfactants mixed with rifampicin.
    Kolomaznik M; Calkovska A; Herting E; Stichtenoth G
    Adv Exp Med Biol; 2015; 839():31-9. PubMed ID: 25252905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of mycobacterial lipids on surface properties of Curosurf: implications for lung surfactant dysfunction in tuberculosis.
    Chimote G; Banerjee R
    Respir Physiol Neurobiol; 2008 Jun; 162(1):73-9. PubMed ID: 18515195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of budesonide and salbutamol on surfactant properties.
    Palmer D; Schürch S; Belik J
    J Appl Physiol (1985); 2000 Sep; 89(3):884-90. PubMed ID: 10956330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interfacial organizations of gel phospholipid and cholesterol in bovine lung surfactant films.
    Nag K; Fritzen-Garcia M; Devraj R; Panda AK
    Langmuir; 2007 Apr; 23(8):4421-31. PubMed ID: 17341098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of clinical pulmonary surfactants using atomic force microscopy.
    Zhang H; Fan Q; Wang YE; Neal CR; Zuo YY
    Biochim Biophys Acta; 2011 Jul; 1808(7):1832-42. PubMed ID: 21439262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of pulmonary surfactant adsorption by serum and the mechanisms of reversal by hydrophilic polymers: theory.
    Zasadzinski JA; Alig TF; Alonso C; Bernardino de la Serna J; Perez-Gil J; Taeusch HW
    Biophys J; 2005 Sep; 89(3):1621-9. PubMed ID: 16006630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical interaction between corticosteroids and natural surfactant preparation: implications for pulmonary drug delivery using surfactant a a carrier.
    Wang YE; Zhang H; Fan Q; Neal CR; Zuo YY
    Soft Matter; 2012 Jan; 8(2):504-511. PubMed ID: 28747989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunction of pulmonary surfactant mediated by phospholipid oxidation is cholesterol-dependent.
    Al-Saiedy M; Pratt R; Lai P; Kerek E; Joyce H; Prenner E; Green F; Ling CC; Veldhuizen R; Ghandorah S; Amrein M
    Biochim Biophys Acta Gen Subj; 2018 Apr; 1862(4):1040-1049. PubMed ID: 29413906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cholesterol and amyloid-β peptide on structure and function of mixed-lipid films and pulmonary surfactant BLES: an atomic force microscopy study.
    Hane F; Drolle E; Leonenko Z
    Nanomedicine; 2010 Dec; 6(6):808-14. PubMed ID: 20493966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.